• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

Glioblastoma Multiforme Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

The global glioblastoma multiforme treatment market is expected to grow at a CAGR of around 11% during 2019-2024. Glioblastoma multiforme, also known as grade IV astrocytoma, is a malignant grade IV brain tumor that rapidly spreads within the brain cells and can also infect the nearby cells. Since it is characterized by rapid cell degeneration, it creates immense pressure on the brain resulting in severe headaches and seizures. Although the exact cause of the diseases is still unknown, several factors including rare hereditary disorders such as Turcot syndrome are believed to be its cause. It is one of the most lethal forms of brain cancer and is treatment-resistant in nature, wherein the patient has an extremely short survival period post-diagnosis. The current treatment procedure of the disease includes surgical resection, chemotherapy and radiation.

Global Glioblastoma Multiforme Treatment Market Report

Increasing prevalence of oncological diseases and a growing geriatric population across the globe are among the key factors driving the market growth. Furthermore, the development of advanced treatment methods that counter the resistive properties of glioma stem cells is also positively influencing the market growth. Additionally, increasing research and development (R&D) activities in molecular biotechnology and gene therapy for cancer and related diseases have facilitated the development of various biological drugs. These drugs assist in diminishing the side-effects of the existing treatment methods, thus creating broader acceptance amongst patients. Moreover, initiatives undertaken by several governments across the globe to improve healthcare infrastructure, along with the rising awareness of the availability of various therapies, are further expected to create a positive outlook for the market.

IMARC Group’s latest report provides a deep insight into the global glioblastoma multiforme treatment market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the glioblastoma multiforme treatment market in any manner.

Report Coverage:

  • Historical, Current and Future Market Trends
     
  • Market Breakup by Drug Type:
    • Temozolomide 
    • Bevacizumab
    • Carmustine
    • Radiosensitizers
    • Others
       
  • Market Breakup by Route of Administration:
    • Oral
    • Parenteral
       
  • Market Breakup by Type of Molecule:
    • Small Molecule
    • Biologics
       
  • Market Breakup by Distribution Channel:
    • Hospitals
    • Pharmacies
    • Others
       
  • Market Breakup by Region:
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • Latin America

 

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Sun Pharmaceutical Industries, Celldex Therapeutics, Pfizer, F. Hoffmann La Roche, Bristol-Myers Squibb, Teva Pharmaceuticals, Exelixis, Angiochem, Arbor Pharmaceuticals, etc.

Key Questions Answered in This Report:

  • How has the global glioblastoma multiforme treatment market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global glioblastoma multiforme treatment industry?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the type of molecule?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the global glioblastoma multiforme treatment industry?
  • What are the key driving factors and challenges in the global glioblastoma multiforme treatment industry?
  • What is the structure of the global glioblastoma multiforme treatment industry and who are the key players?
  • What is the degree of competition in the global glioblastoma multiforme treatment industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Glioblastoma Multiforme Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Market Breakup by Drug Type
    5.4    Market Breakup by Route of Administration
    5.5    Market Breakup by Type of Molecule
    5.6    Market Breakup by Distribution Channel
    5.7    Market Breakup by Region
    5.8    Market Forecast
6    Market Breakup by Drug Type
    6.1    Temozolomide
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Bevacizumab
        6.2.1    Market Trends
        6.2.2    Market Forecast
    6.3    Carmustine
        6.3.1    Market Trends
        6.3.2    Market Forecast
    6.4    Radiosensitizers
        6.4.1    Market Trends
        6.4.2    Market Forecast
    6.5    Others
        6.5.1    Market Trends
        6.5.2    Market Forecast
7    Market Breakup by Route of Administration
    7.1    Oral
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Parenteral
        7.2.1    Market Trends
        7.2.2    Market Forecast
8    Market Breakup by Type of Molecule
    8.1    Small Molecule
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Biologics
        8.2.1    Market Trends
        8.2.2    Market Forecast
9    Market Breakup by Distribution Channel
    9.1    Hospital
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Pharmacies
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Others
        9.3.1    Market Trends
        9.3.2    Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1    Market Trends
        10.1.2    Market Forecast
    10.2    Europe
        10.2.1    Market Trends
        10.2.2    Market Forecast
    10.3    Asia Pacific
        10.3.1    Market Trends
        10.3.2    Market Forecast
    10.4    Middle East and Africa
        10.4.1    Market Trends
        10.4.2    Market Forecast
    10.5    Latin America
        10.5.1    Market Trends
        10.5.2    Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Sun Pharmaceutical Industries 
        15.3.2    Celldex Therapeutics 
        15.3.3    Pfizer 
        15.3.4    F.Hoffmann La Roche 
        15.3.5    Bristol-Myers Squibb 
        15.3.6    Teva Pharmaceuticals 
        15.3.7    Exelixis 
        15.3.8    Angiochem 
        15.3.9    Arbor Pharmaceuticals 

List of Figures

Figure 1: Global: Glioblastoma Multiforme Treatment Market: Major Drivers and Challenges
Figure 2: Global: Glioblastoma Multiforme Treatment Market: Sales Value (in Billion US$), 2013-2018
Figure 3: Global: Glioblastoma Multiforme Treatment Market: Breakup by Drug Type (in %), 2018
Figure 4: Global: Glioblastoma Multiforme Treatment Market: Breakup by Route of Administration (in %), 2018
Figure 5: Global: Glioblastoma Multiforme Treatment Market: Breakup by Type of Molecule (in %), 2018
Figure 6: Global: Glioblastoma Multiforme Treatment Market: Breakup by Distribution Channel (in %), 2018
Figure 7: Global: Glioblastoma Multiforme Treatment Market: Breakup by Region (in %), 2018
Figure 8: Global: Glioblastoma Multiforme Treatment Market Forecast: Sales Value (in Billion US$), 2019-2024
Figure 9: Global: Glioblastoma Multiforme Treatment Industry: SWOT Analysis
Figure 10: Global: Glioblastoma Multiforme Treatment Industry: Value Chain Analysis
Figure 11: Global: Glioblastoma Multiforme Treatment Industry: Porter’s Five Forces Analysis
Figure 12: Global: Glioblastoma Multiforme Treatment (Temozolomide) Market: Sales Value (in Million US$), 2013-2018
Figure 13: Global: Glioblastoma Multiforme Treatment (Temozolomide) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 14: Global: Glioblastoma Multiforme Treatment (Bevacizumab) Market: Sales Value (in Million US$), 2013-2018
Figure 15: Global: Glioblastoma Multiforme Treatment (Bevacizumab) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 16: Global: Glioblastoma Multiforme Treatment (Carmustine) Market: Sales Value (in Million US$), 2013-2018
Figure 17: Global: Glioblastoma Multiforme Treatment (Carmustine) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 18: Global: Glioblastoma Multiforme Treatment (Radiosensitizers) Market: Sales Value (in Million US$), 2013-2018
Figure 19: Global: Glioblastoma Multiforme Treatment (Radiosensitizers) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 20: Global: Glioblastoma Multiforme Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2013-2018
Figure 21: Global: Glioblastoma Multiforme Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 22: Global: Glioblastoma Multiforme Treatment (Oral) Market: Sales Value (in Million US$), 2013-2018
Figure 23: Global: Glioblastoma Multiforme Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 24: Global: Glioblastoma Multiforme Treatment (Parenteral) Market: Sales Value (in Million US$), 2013-2018
Figure 25: Global: Glioblastoma Multiforme Treatment (Parenteral) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 26: Global: Glioblastoma Multiforme Treatment (Small Molecule) Market: Sales Value (in Million US$), 2013-2018
Figure 27: Global: Glioblastoma Multiforme Treatment (Small Molecule) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 28: Global: Glioblastoma Multiforme Treatment (Biologics) Market: Sales Value (in Million US$), 2013-2018
Figure 29: Global: Glioblastoma Multiforme Treatment (Biologics) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 30: Global: Glioblastoma Multiforme Treatment Market: Sales through Hospitals (in Million US$), 2013-2018
Figure 31: Global: Glioblastoma Multiforme Treatment Market Forecast: Sales through Hospitals (in Million US$), 2019-2024
Figure 32: Global: Glioblastoma Multiforme Treatment Market: Sales through Pharmacies (in Million US$), 2013-2018
Figure 33: Global: Glioblastoma Multiforme Treatment Market Forecast: Sales through Pharmacies (in Million US$), 2019-2024
Figure 34: Global: Glioblastoma Multiforme Treatment Market: Sales through Other Distribution Channels (in Million US$), 2013-2018
Figure 35: Global: Glioblastoma Multiforme Treatment Market Forecast: Sales through Other Distribution Channels (in Million US$), 2019-2024
Figure 36: North America: Glioblastoma Multiforme Treatment Market: Sales Value (in Million US$), 2013-2018
Figure 37: North America: Glioblastoma Multiforme Treatment Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 38: Europe: Glioblastoma Multiforme Treatment Market: Sales Value (in Million US$), 2013-2018
Figure 39: Europe: Glioblastoma Multiforme Treatment Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 40: Asia Pacific: Glioblastoma Multiforme Treatment Market: Sales Value (in Million US$), 2013-2018
Figure 41: Asia Pacific: Glioblastoma Multiforme Treatment Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 42: Middle East and Africa: Glioblastoma Multiforme Treatment Market: Sales Value (in Million US$), 2013-2018
Figure 43: Middle East and Africa: Glioblastoma Multiforme Treatment Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 44: Latin America: Glioblastoma Multiforme Treatment Market: Sales Value (in Million US$), 2013-2018
Figure 45: Latin America: Glioblastoma Multiforme Treatment Market Forecast: Sales Value (in Million US$), 2019-2024

List of Tables

Table 1: Global: Glioblastoma Multiforme Treatment Market: Key Industry Highlights, 2018 and 2024
Table 2: Global: Glioblastoma Multiforme Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2019-2024
Table 3: Global: Glioblastoma Multiforme Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2019-2024
Table 4: Global: Glioblastoma Multiforme Treatment Market Forecast: Breakup by Type of Molecule (in Million US$), 2019-2024
Table 5: Global: Glioblastoma Multiforme Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2019-2024
Table 6: Global: Glioblastoma Multiforme Treatment Market Forecast: Breakup by Region (in Million US$), 2019-2024
Table 7: Global: Glioblastoma Multiforme Treatment Market Structure
Table 8: Global: Glioblastoma Multiforme Treatment Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 1999

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links